首页> 外文OA文献 >Differential Modulation of Thresholds for Intracranial Self-Stimulation by mGlu5 Positive and Negative Allosteric Modulators: Implications for Effects on Drug Self-Administration
【2h】

Differential Modulation of Thresholds for Intracranial Self-Stimulation by mGlu5 Positive and Negative Allosteric Modulators: Implications for Effects on Drug Self-Administration

机译:mGlu5阳性和阴性变构调节剂对颅内自我刺激阈值的差异调节:对药物自我管理的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pharmacological manipulation of the type 5 metabotropic glutamate (mGlu5) receptor alters various addiction related behaviors such as drug self-administration and the extinction and reinstatement of drug-seeking behavior. However, the effects of pharmacological modulation of mGlu5 receptors on brain reward function have not been widely investigated. We examined the effects of acute administration of positive and negative allosteric modulators (PAMs and NAMs, respectively) on brain reward function by assessing thresholds for intracranial self-stimulation (ICSS). In addition, when acute effects were observed, we examined changes in ICSS thresholds following repeated administration. Male Sprague-Dawley rats were implanted with bipolar electrodes into the medial forebrain bundle and trained to respond for ICSS, followed by assessment of effects of mGlu5 ligands on ICSS thresholds using a discrete trials current–intensity threshold determination procedure. Acute administration of the selective mGlu5 NAMs MTEP (0, 0.3, 1, or 3 mg/kg) and fenobam (0, 3, 10, or 30 mg/kg) dose-dependently increased ICSS thresholds (∼70% at the highest dose tested), suggesting a deficit in brain reward function. Acute administration of the mGlu5 PAMs CDPPB (0, 10, 30, and 60 mg/kg) or ADX47273 (0, 10, 30, and 60 mg/kg) was without effect at any dose tested. When administered once daily for five consecutive days, the development of tolerance to the ability of threshold-elevating doses of MTEP and fenobam to increase ICSS thresholds was observed. We conclude that mGlu5 PAMs and NAMs differentially affect brain reward function, and that tolerance to the ability of mGlu5 NAMs to reduce brain reward function develops with repeated administration. These brain reward deficits should be taken into consideration when interpreting acute effects of mGlu5 NAMs on drug self-administration, and repeated administration of these ligands may be an effective method to reduce these deficits.
机译:对5型代谢型谷氨酸(mGlu5)受体的药理处理改变了各种与成瘾有关的行为,例如药物自我给药以及药物寻求行为的灭绝和恢复。但是,尚未广泛研究mGlu5受体的药理调节对大脑奖赏功能的影响。我们通过评估颅内自我刺激(ICSS)的阈值,检查了正向和负向变构调节剂(分别为PAM和NAM)的急性给药对大脑奖赏功能的影响。另外,当观察到急性影响时,我们检查了重复给药后ICS阈值的变化。将雄性Sprague-Dawley大鼠的双极电极植入前脑内侧束,并训练其对ICSS的反应,然后使用离散试验电流强度阈值确定程序评估mGlu5配体对ICSS阈值的影响。急性给予选择性mGlu5 NAM MTEP(0、0.3、1或3μmg/ kg)和芬诺班(0、3、10或30μmg/ kg)剂量依赖性地增加了ICSS阈值(最高剂量时约为70%)测试),提示大脑奖励功能不足。在任何测试剂量下,mGlu5 PAM CDPPB(0、10、30和60μmg/ kg)或ADX47273(0、10、30和60μmg/ kg)的急性给药均无效。当连续五天每天给药一次时,观察到对提高阈值剂量的MTEP和fenobam增加ICSS阈值能力的耐受性的发展。我们得出的结论是,mGlu5 PAM和NAM差异地影响大脑的奖励功能,并且对mGlu5 NAM降低大脑奖励功能的能力的耐受性随着重复给药而发展。在解释mGlu5 NAM对药物自我给药的急性影响时,应考虑这些大脑奖赏缺陷,并且重复施用这些配体可能是减少这些缺陷的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号